[Form 4] Tivic Health Systems, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Sheryle Bolton, a director of Tivic Health Systems, Inc. (TIVC), was granted a stock option on 08/06/2025 to purchase 12,500 shares of common stock at an exercise price of $3.32 per share. The option is held directly and covers 12,500 underlying shares. The option expires on 08/05/2035.

The grant vests in four equal quarterly installments (rounded down) measured from the grant date, with 100% vesting upon the first anniversary of the grant. The form was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Director Sheryle Bolton received a clear, time-based equity award: 12,500 stock options with explicit quarterly vesting and full vesting after one year
• Long-term alignment: Option expiration in 2035 provides a multi-year incentive horizon

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity award; grants management alignment but no evidence here of material dilution or extraordinary terms.

The filing documents a standard director equity grant: a stock option for 12,500 shares at an exercise price of $3.32, exercisable under a vesting schedule of four equal quarterly installments and fully vested after one year. The option is direct and expires on 08/05/2035. From a governance perspective, the disclosure is complete on grant mechanics and vesting. The filing does not provide information on total outstanding shares, prior holdings, or option plan limits, so materiality relative to shareholder dilution cannot be assessed from this form alone.

Compensation Analyst

TL;DR: Compensation details are clear: 12,500 options at $3.32 with time-based quarter vesting and a 10-year term; appears routine.

The derivative reported is a stock option to purchase 12,500 shares with an exercise price of $3.32 and an expiration date of 08/05/2035. The vesting triggers are time-based: four equal quarterly installments culminating in full vesting at one year. The form confirms direct ownership of the option post-grant. Absent additional pay-rate, grant-date valuation, or company-wide compensation context, this grant reads as a typical long-term incentive for a director rather than an extraordinary compensation event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bolton Sheryle

(Last) (First) (Middle)

47685 LAKEVIEW BOULEVARD

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tivic Health Systems, Inc. [ TIVC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$3.32	08/06/2025		A		12,500		(1)	08/05/2035	Common Stock	12,500	$0.00	12,500	D

Explanation of Responses:

1. The stock option vests in a series of four (4) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the grant date, such that 100% of the stock option will be vested upon the first anniversary of the grant date.

	/s/ Jennifer Ernst, attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for TIVC disclose about Sheryle Bolton's transaction?

The Form 4 shows a grant of a stock option to purchase 12,500 shares with an exercise price of $3.32, acquired on 08/06/2025.

What is the vesting schedule for the TIVC option granted to Sheryle Bolton?

The option vests in a series of four equal quarterly installments, rounded downward, with 100% vesting upon the first anniversary of the grant date.

When does the option granted to the TIVC director expire?

The option expiration date reported is 08/05/2035.

Is the option held directly or indirectly for the TIVC reporting person?

The Form 4 lists the ownership form as Direct (D) for the 12,500-option award.

What is the exercise price of the derivative security in the TIVC Form 4?

The conversion/exercise price reported for the stock option is $3.32 per share.

Does the Form 4 indicate how many derivative securities are owned after the transaction?

Yes; the Form 4 reports 12,500 derivative securities beneficially owned following the reported transaction.